TY - JOUR
T1 - Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study
AU - CRIC Study Investigators
AU - Brown, Landon
AU - Luciano, Alison
AU - Pendergast, Jane
AU - Khairallah, Pascale
AU - Anderson, Cheryl A.M.
AU - Sondheimer, James
AU - Hamm, L. Lee
AU - Ricardo, Ana C.
AU - Rao, Panduranga
AU - Rahman, Mahboob
AU - Miller, Edgar R.
AU - Sha, Daohang
AU - Xie, Dawei
AU - Feldman, Harold I.
AU - Asplin, John
AU - Wolf, Myles
AU - Scialla, Julia J.
AU - Appel, Lawrence J.
AU - Go, Alan S.
AU - He, Jiang
AU - Kusek, John W.
AU - Lash, James P.
AU - Rao, Panduranga S.
AU - Townsend, Raymond R.
N1 - Funding Information:
Lawrence J. Appel, MD, MPH, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, Jiang He, MD, PhD, John W. Kusek, PhD, James P. Lash, MD, Panduranga S. Rao, MD, Mahboob Rahman, MD, Raymond R. Townsend, MD. Landon Brown, MD, Alison Luciano, PhD, Jane Pendergast, PhD, Pascale Khairallah, MD, Cheryl A.M. Anderson, PhD, MPH, MS, James Sondheimer, MD, L. Lee Hamm, MD, Ana C. Ricardo, MD, Panduranga Rao, MD, Mahboob Rahman, MD, Edgar R. Miller III, MD, PhD, Daohang Sha, PhD, Dawei Xie, PhD, Harold I. Feldman, MD, MSCE, John Asplin, MD, Myles Wolf, MD, MMSc, and Julia J. Scialla MD, MHS. Research idea and study design: LB, PK, CAMA, MR, PR, DS, DX, HIF, JA, MW, JJS; data acquisition: CAMA, JS, LLH, ACR, PR, MR, ERM, DS, DX, HIF, JA, MW, JJS; data analysis/interpretation: all authors; statistical analysis: LB, AL, JP, DS, DX, JJS; supervision or mentorship: MW, JJS. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. This study was supported in part by K23DK095949 (Dr Scialla), K24DK093723 (Dr Wolf), and R01DK081374 (Dr Wolf), each from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr Brown was supported in part by a Stead Resident Research Award from the Duke University Department of Medicine. Drs Pendergast and Luciano were supported by the Claude D. Pepper Older Americans Independence Center (2P30AG028716-6) from the National Institute of Aging. Funding for the CRIC Study was obtained under a cooperative agreement from NIDDK (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by the Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award (CTSA) National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University UL1 TR-000424, University of Maryland General Clinical Research Center M01 RR-16500, Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the NCATS component of the NIH and NIH roadmap for Medical Research, Michigan Institute for Clinical and Health Research (MICHR) UL1TR000433, University of Illinois at Chicago CTSA UL1RR029879, Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases P20 GM109036, Kaiser Permanente NIH/National Center for Research Resources UCSF-CTSI UL1 RR-024131. The funders did not have a direct role in study design; data collection, analysis, or reporting; or the decision to submit for publication. The authors declare that they have no relevant financial interests. We gratefully acknowledge the contributions of CRIC participants and staff. Received June 8, 2018. Evaluated by 2 external peer reviewers and a statistician, with editorial input from an Acting Editor-in-Chief (Editorial Board Member Kevan R. Polkinghorne, PhD). Accepted in revised form December 28. 2018. The involvement of an Acting Editor-in-Chief to handle the peer-review and decision-making processes was to comply with AJKD's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.
Funding Information:
This study was supported in part by K23DK095949 (Dr Scialla), K24DK093723 (Dr Wolf), and R01DK081374 (Dr Wolf), each from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr Brown was supported in part by a Stead Resident Research Award from the Duke University Department of Medicine. Drs Pendergast and Luciano were supported by the Claude D. Pepper Older Americans Independence Center (2P30AG028716-6) from the National Institute of Aging. Funding for the CRIC Study was obtained under a cooperative agreement from NIDDK (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by the Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award (CTSA) National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University UL1 TR-000424, University of Maryland General Clinical Research Center M01 RR-16500, Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the NCATS component of the NIH and NIH roadmap for Medical Research, Michigan Institute for Clinical and Health Research (MICHR) UL1TR000433, University of Illinois at Chicago CTSA UL1RR029879, Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases P20 GM109036, Kaiser Permanente NIH/National Center for Research Resources UCSF-CTSI UL1 RR-024131. The funders did not have a direct role in study design; data collection, analysis, or reporting; or the decision to submit for publication.
Publisher Copyright:
© 2019
PY - 2019/8
Y1 - 2019/8
N2 - Rationale & Objective: Higher urine net acid excretion (NAE) is associated with slower chronic kidney disease progression, particularly in patients with diabetes mellitus. To better understand potential mechanisms and assess modifiable components, we explored independent predictors of NAE in the CRIC (Chronic Renal Insufficiency Cohort) Study. Study Design: Cross-sectional. Setting & Participants: A randomly selected subcohort of adults with chronic kidney disease enrolled in the CRIC Study with NAE measurements. Predictors: A comprehensive set of variables across prespecified domains including demographics, comorbid conditions, medications, laboratory values, diet, physical activity, and body composition. Outcome: 24-hour urine NAE. Analytical Approach: NAE was defined as the sum of urine ammonium and calculated titratable acidity in a subset of CRIC participants. 22 individuals were excluded for urine pH < 4 (n = 1) or ≥7.4 (n = 19) or extreme outliers of NAE values (n = 2). From an analytic sample of 978, we identified the association of individual variables with NAE in the selected domains using linear regression. We estimated the percent variance explained by each domain using the adjusted R2 from a domain-specific model. Results: Mean NAE was 33.2 ± 17.4 (SD) mEq/d. Multiple variables were associated with NAE in models adjusted for age, sex, estimated glomerular filtration rate (eGFR), race/ethnicity, and body surface area, including insulin resistance, dietary potential renal acid load, and a variety of metabolically active medications (eg, metformin, allopurinol, and nonstatin lipid agents). Body size, as indicated by body surface area, body mass index, or fat-free mass; race/ethnicity; and eGFR also were independently associated with NAE. By domains, more variance was explained by demographics, body composition, and laboratory values, which included eGFR and serum bicarbonate level. Limitations: Cross-sectional; use of stored biological samples. Conclusions: NAE relates to several clinical domains including body composition, kidney function, and diet, but also to metabolic factors such as insulin resistance and the use of metabolically active medications.
AB - Rationale & Objective: Higher urine net acid excretion (NAE) is associated with slower chronic kidney disease progression, particularly in patients with diabetes mellitus. To better understand potential mechanisms and assess modifiable components, we explored independent predictors of NAE in the CRIC (Chronic Renal Insufficiency Cohort) Study. Study Design: Cross-sectional. Setting & Participants: A randomly selected subcohort of adults with chronic kidney disease enrolled in the CRIC Study with NAE measurements. Predictors: A comprehensive set of variables across prespecified domains including demographics, comorbid conditions, medications, laboratory values, diet, physical activity, and body composition. Outcome: 24-hour urine NAE. Analytical Approach: NAE was defined as the sum of urine ammonium and calculated titratable acidity in a subset of CRIC participants. 22 individuals were excluded for urine pH < 4 (n = 1) or ≥7.4 (n = 19) or extreme outliers of NAE values (n = 2). From an analytic sample of 978, we identified the association of individual variables with NAE in the selected domains using linear regression. We estimated the percent variance explained by each domain using the adjusted R2 from a domain-specific model. Results: Mean NAE was 33.2 ± 17.4 (SD) mEq/d. Multiple variables were associated with NAE in models adjusted for age, sex, estimated glomerular filtration rate (eGFR), race/ethnicity, and body surface area, including insulin resistance, dietary potential renal acid load, and a variety of metabolically active medications (eg, metformin, allopurinol, and nonstatin lipid agents). Body size, as indicated by body surface area, body mass index, or fat-free mass; race/ethnicity; and eGFR also were independently associated with NAE. By domains, more variance was explained by demographics, body composition, and laboratory values, which included eGFR and serum bicarbonate level. Limitations: Cross-sectional; use of stored biological samples. Conclusions: NAE relates to several clinical domains including body composition, kidney function, and diet, but also to metabolic factors such as insulin resistance and the use of metabolically active medications.
KW - CKD progression
KW - Net acid excretion (NAE)
KW - acid load
KW - acidosis
KW - chronic kidney disease (CKD)
KW - diabetes mellitus
KW - diet
KW - metabolism
KW - nutrition
KW - urine ammonium
KW - urine pH
UR - http://www.scopus.com/inward/record.url?scp=85063236286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063236286&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2018.12.043
DO - 10.1053/j.ajkd.2018.12.043
M3 - Article
C2 - 30910373
AN - SCOPUS:85063236286
SN - 0272-6386
VL - 74
SP - 203
EP - 212
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 2
ER -